Video

Dr Jeffrey Scott on Pharma's Role in Understanding the Value of Novel, Expensive Therapies

Jeffrey A. Scott, MD, chief medical officer, Integra Connect, discusses how pharma can help community oncologists understand the value of novel and expensive therapies.

Jeffrey A. Scott, MD, chief medical officer, Integra Connect, discusses how pharma can help community oncologists understand the value of novel and expensive therapies.

Transcript

How can pharma be leveraged to help community oncologists better understand the value of novel and expensive therapies?

Back in the 80s and 90s, the value to the medical oncologist was the contract, the rebate, the discount. I think those days are going away. I think pharma’s role today in helping me is to support me with the use of real-world data, whether it’s clinical outcomes that occur once a drug is launched, or how does their drug compare in total cost of care versus another drug. Since I don’t always have the 2 new drugs compared head to head, I have to look at other sources of data. So, if I found out that one drug may use less growth factors and have less hospitalization, in the new world order of value-based care, that’s a big win. So, I think pharma needs to build the databases and the stories to support their drugs and the total picture of the care of the patient, not just on the drug side; how it impacts cost across that.

Related Videos
Marla Black Morgan, MD, Phoebe Neurology Associates
Toby Maher, MD, PhD, professor of clinical medicine, Keck School of Medicine at USC
Nini Wu, MD, Navista
Matthew Viggiano, MD, internal medicine resident, Temple University Hospital
Krunal Patel, MD, pulmonary and critical care fellow, Temple University Hospital
M. Bradley Drummond, MD, MHS, professor of medicine, University of North Carolina at Chapel Hill
Sanjay Ramakrishnan, MD, senior lecturer, University of Western Australia
Michael Goulet, DO, pulmonary and critical care fellow, Temple University Hospital
Tom Belmon, CAP, GPBCH
Tom Belmont
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo